Beyond Raynaud's phenomenon hides very early systemic sclerosis: The assessment of organ involvement is always mandatory

Rheumatology

Volumn 50, Issue 2, 2011, Pages 250-251

  Czirják, László ^a   Matucci Cerinic, Marco ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTHRITIS; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; ECHOCARDIOGRAPHY; EDITORIAL; EUROPE; FINGER INJURY; HEARTBURN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MANOMETRY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SKIN ULCER; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

EARLY DIAGNOSIS; HUMANS; PREDICTIVE VALUE OF TESTS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; TIME FACTORS;

EID: 78751689524     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq374     Document Type: Editorial

References (10)

1. Valentini G, Cuomo G, Abignano G et al. Early systemic sclerosis: assessment of clinical and preclinical organ involvement in patients with different disease features. Rheumatology 2011;50:317-23.
2. Matucci-Cerinic M, Allanore Y, Czirják L et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009;68: 1377-80.
3. Koenig M, Joyal F, Fritzler MJ et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis. A twenty-year prospective study of 586 patients with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
4. Avouac J, Fransen J, Walker UA et al. Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS): results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group (EUSTAR). Ann Rheum Dis 2010;69(Suppl. 3):128.
5. Matucci-Cerinic M, Seibold JR. Digital ulcers and outcomes assessment in scleroderma. Rheumatology 2008; 47(Suppl. 5):v46-7.
6. Allanore Y, Meune C, Vonk M et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research Group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-221.
7. Sjölund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A. Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 2005;17: 1205-12.
8. Hachulla E, Launay D, Mouthon L et al. French PAH-SSc Network Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest 2009;136: 1211-9.
9. Miniati I, Guiducci S, Conforti ML et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009;68:94-8.
10. Launay D, Marjanovic Z, de Bazelaire C et al. Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring. J Rheumatol 2009;36:1460-3.